Skip to main content
Continue to love this myositis diagram. Seems to be getting ever more complicated though! @DrLisaCS @RheumNow #RNL2024 h

Richard Conway RichardPAConway

2 years 8 months ago
Continue to love this myositis diagram. Seems to be getting ever more complicated though! @DrLisaCS @RheumNow #RNL2024 https://t.co/eXz6144y3y
Cancer and Myositis #RNL2024 @RheumNow
@DrLisaCS
Dermatomyositis risks - TIF1y is highest risk, followed by NXP2
Protec

Eric Dein ericdeinmd

2 years 8 months ago
Cancer and Myositis #RNL2024 @RheumNow @DrLisaCS Dermatomyositis risks - TIF1y is highest risk, followed by NXP2 Protective features: childhood onset, ILD, arthralgias Cancer and myositis often present w/in 1 yr before or after Cancer is major cause of death
Are we overprescribing because guidelines may be skewed to favor the pharmaceutical industry? Interesting questions pose

TheDaoIndex KDAO2011

2 years 8 months ago
Are we overprescribing because guidelines may be skewed to favor the pharmaceutical industry? Interesting questions posed by Dr. A Kavanaugh #RNL2024 @rheumnow https://t.co/wEwHaWNY5k
Dr. A Kavanaugh discussed Ethics #RNL2024: publication bias where positive results are likely to be published compared t

TheDaoIndex KDAO2011

2 years 8 months ago
Dr. A Kavanaugh discussed Ethics #RNL2024: publication bias where positive results are likely to be published compared to those with no effects -- this is a sham study with made up data submitted to 2 different ortho journals. @rheumnow https://t.co/j6gVgA67nC
Kavanaugh on Medical Ethics
#RNL2024 @RheumNow
Bias in research for ++ outcomes leads to fudging/biased interpretations

Eric Dein ericdeinmd

2 years 8 months ago
Kavanaugh on Medical Ethics #RNL2024 @RheumNow Bias in research for ++ outcomes leads to fudging/biased interpretations of results Fabricated study results submitted to orthopedic journals: - 97% acceptance for positive result, 80% for no-difference result. Bias towards +outcome https://t.co/x7JJabSs4z
Kavanaugh on Medical Ethics
#RNL2024 @RheumNow
How do we informed consent?
- How to fully inform pts in complex researc

Eric Dein ericdeinmd

2 years 8 months ago
Kavanaugh on Medical Ethics #RNL2024 @RheumNow How do we informed consent? - How to fully inform pts in complex research? - Or paternalistic to not provide detailed info - How deep to disc risk/ben? - Easier to study in countries w/o good SoC Prior hx: prisoners, Nazi, Tuskegee
@drcassysims recommends @NIH resource: https://t.co/ebtvc2zYbE to guide lactation- updated and run by pharmacists. #RNL

TheDaoIndex KDAO2011

2 years 8 months ago
@drcassysims recommends @NIH resource: https://t.co/ebtvc2zYbE to guide lactation- updated and run by pharmacists. #RNL2024 @rheumnow
MTX and cyclophosphamide are the two drugs @DrCassySims recommends holding during breast feeding in our vasculitis patie

Dr. Rachel Tate uptoTate

2 years 8 months ago
MTX and cyclophosphamide are the two drugs @DrCassySims recommends holding during breast feeding in our vasculitis patients. #RNL2024 @RheumNow
Do you get extra-cranial imaging in your GCA patients? #rheumtwitter #RNL2024 @RheumNow @anisha_dua @DrCassySims @philse

Dr. Rachel Tate uptoTate

2 years 8 months ago
Do you get extra-cranial imaging in your GCA patients? #rheumtwitter #RNL2024 @RheumNow @anisha_dua @DrCassySims @philseo
Dr P Seo answers audience questions…he does not check ANCA levels regularly as results do not impact his actions but m

TheDaoIndex KDAO2011

2 years 8 months ago
Dr P Seo answers audience questions…he does not check ANCA levels regularly as results do not impact his actions but may induce anxiety #Vasculitis #RNL2024 @RheumNow https://t.co/GV62DF7s3y
@DrCassySims checks APS ab on ALL pregnant (vasculitis) patients. "HCQ decreases neonatal lupus risk by half, meaning gr

Dr. Rachel Tate uptoTate

2 years 8 months ago
@DrCassySims checks APS ab on ALL pregnant (vasculitis) patients. "HCQ decreases neonatal lupus risk by half, meaning great reward for little risk." CS at #RNL2024 @RheumNow
While #dupilumab can be used for #EGPA, be careful about using it in pts with high eosinophilia; don't taper steroids to

TheDaoIndex KDAO2011

2 years 8 months ago
While #dupilumab can be used for #EGPA, be careful about using it in pts with high eosinophilia; don't taper steroids too rapidly if you use this drug. - Dr P Seo @rheumnow #RNL2024 https://t.co/YKQdtvCS0M
×